nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Taste metallic—Metformin—metabolic syndrome X	0.161	0.197	CcSEcCtD
Gallamine Triethiodide—Upset stomach—Metformin—metabolic syndrome X	0.078	0.0956	CcSEcCtD
Gallamine Triethiodide—Blood disorder—Metformin—metabolic syndrome X	0.0612	0.075	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Metformin—metabolic syndrome X	0.0339	0.0415	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Metformin—metabolic syndrome X	0.0332	0.0407	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Metformin—metabolic syndrome X	0.0307	0.0377	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Metformin—metabolic syndrome X	0.0257	0.0315	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Metformin—metabolic syndrome X	0.0255	0.0313	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Metformin—metabolic syndrome X	0.024	0.0294	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Metformin—metabolic syndrome X	0.0238	0.0292	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Metformin—metabolic syndrome X	0.0219	0.0268	CcSEcCtD
Gallamine Triethiodide—Malaise—Metformin—metabolic syndrome X	0.0201	0.0247	CcSEcCtD
Gallamine Triethiodide—ACHE—Synthesis, secretion, and deacylation of Ghrelin—PLA2G7—metabolic syndrome X	0.0197	0.107	CbGpPWpGaD
Gallamine Triethiodide—Chest pain—Metformin—metabolic syndrome X	0.019	0.0233	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.0189	0.0232	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Metformin—metabolic syndrome X	0.0179	0.0219	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Metformin—metabolic syndrome X	0.0177	0.0217	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.0166	0.0204	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Metformin—metabolic syndrome X	0.0164	0.0201	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.0157	0.0193	CcSEcCtD
Gallamine Triethiodide—Fatigue—Metformin—metabolic syndrome X	0.0157	0.0193	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Metformin—metabolic syndrome X	0.015	0.0184	CcSEcCtD
Gallamine Triethiodide—Urticaria—Metformin—metabolic syndrome X	0.0145	0.0178	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Metformin—metabolic syndrome X	0.0144	0.0177	CcSEcCtD
Gallamine Triethiodide—Asthenia—Metformin—metabolic syndrome X	0.0131	0.016	CcSEcCtD
Gallamine Triethiodide—Pruritus—Metformin—metabolic syndrome X	0.0129	0.0158	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Metformin—metabolic syndrome X	0.0125	0.0153	CcSEcCtD
Gallamine Triethiodide—Vomiting—Metformin—metabolic syndrome X	0.0116	0.0142	CcSEcCtD
Gallamine Triethiodide—ACHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—metabolic syndrome X	0.0115	0.0626	CbGpPWpGaD
Gallamine Triethiodide—Rash—Metformin—metabolic syndrome X	0.0115	0.0141	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Metformin—metabolic syndrome X	0.0115	0.0141	CcSEcCtD
Gallamine Triethiodide—Headache—Metformin—metabolic syndrome X	0.0114	0.014	CcSEcCtD
Gallamine Triethiodide—Nausea—Metformin—metabolic syndrome X	0.0108	0.0133	CcSEcCtD
Gallamine Triethiodide—ACHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—metabolic syndrome X	0.00693	0.0376	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Synthesis, secretion, and deacylation of Ghrelin—INS—metabolic syndrome X	0.00592	0.0322	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—metabolic syndrome X	0.00572	0.0311	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—PLA2G7—metabolic syndrome X	0.00544	0.0296	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Monoamine GPCRs—HTR2C—metabolic syndrome X	0.00485	0.0264	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Melatonin metabolism and effects—APOE—metabolic syndrome X	0.00452	0.0246	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Glycerophospholipid biosynthesis—PLA2G6—metabolic syndrome X	0.00443	0.0241	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Monoamine Transport—AGT—metabolic syndrome X	0.00426	0.0232	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Amine ligand-binding receptors—HTR2C—metabolic syndrome X	0.00408	0.0222	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—FGF21—metabolic syndrome X	0.00355	0.0193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—FMO3—metabolic syndrome X	0.00342	0.0186	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—GHRL—metabolic syndrome X	0.00318	0.0173	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—PLA2G6—metabolic syndrome X	0.00309	0.0168	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—ACE—metabolic syndrome X	0.00308	0.0167	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Glycerophospholipid biosynthesis—PLA2G4A—metabolic syndrome X	0.00226	0.0123	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—INS—metabolic syndrome X	0.00219	0.0119	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—GALNT2—metabolic syndrome X	0.00196	0.0106	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—AGT—metabolic syndrome X	0.00195	0.0106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—CNR1—metabolic syndrome X	0.00194	0.0105	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Monoamine Transport—TNF—metabolic syndrome X	0.00193	0.0105	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—LEP—metabolic syndrome X	0.00191	0.0104	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—TOMM40—metabolic syndrome X	0.00182	0.00988	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—INS—metabolic syndrome X	0.00163	0.00887	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.00159	0.00867	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—IGF1—metabolic syndrome X	0.00158	0.00858	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—PLA2G4A—metabolic syndrome X	0.00158	0.00857	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—GCK—metabolic syndrome X	0.00156	0.00849	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—MTNR1B—metabolic syndrome X	0.0013	0.00704	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.00127	0.00693	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.00127	0.00689	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.00122	0.00661	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.00121	0.00657	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.0012	0.00653	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.00105	0.00571	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.00103	0.0056	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.00103	0.00558	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—PLA2G7—metabolic syndrome X	0.00103	0.00558	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000995	0.00541	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000985	0.00535	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—IL6—metabolic syndrome X	0.000955	0.00519	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.000937	0.00509	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.000916	0.00498	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CNR1—metabolic syndrome X	0.000906	0.00492	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—NR3C1—metabolic syndrome X	0.000898	0.00488	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.000841	0.00457	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.000826	0.00449	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000816	0.00444	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000811	0.00441	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.000802	0.00436	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—FMO3—metabolic syndrome X	0.000797	0.00433	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000788	0.00428	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.000784	0.00426	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.000761	0.00413	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000754	0.0041	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000732	0.00398	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00072	0.00391	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000712	0.00387	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MLXIPL—metabolic syndrome X	0.00071	0.00386	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—EPHX2—metabolic syndrome X	0.00071	0.00386	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.000702	0.00382	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	0.000685	0.00372	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—G6PC2—metabolic syndrome X	0.000668	0.00363	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000635	0.00345	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000615	0.00334	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000611	0.00332	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—GHRL—metabolic syndrome X	0.0006	0.00326	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—AGT—metabolic syndrome X	0.000587	0.00319	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ACE—metabolic syndrome X	0.000581	0.00316	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GHRL—metabolic syndrome X	0.000579	0.00315	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—FABP4—metabolic syndrome X	0.000568	0.00309	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000558	0.00303	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CNR1—metabolic syndrome X	0.000549	0.00298	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HSD11B1—metabolic syndrome X	0.000538	0.00293	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000522	0.00284	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000508	0.00276	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000498	0.00271	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.000495	0.00269	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—G6PD—metabolic syndrome X	0.00048	0.00261	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000473	0.00257	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HDAC3—metabolic syndrome X	0.000468	0.00254	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000467	0.00254	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF2—metabolic syndrome X	0.000464	0.00252	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.000463	0.00251	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LPA—metabolic syndrome X	0.000458	0.00249	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GCKR—metabolic syndrome X	0.000458	0.00249	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLA2G6—metabolic syndrome X	0.000443	0.00241	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000443	0.00241	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.00044	0.00239	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOA5—metabolic syndrome X	0.000439	0.00238	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000426	0.00232	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL5—metabolic syndrome X	0.000425	0.00231	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000418	0.00227	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000413	0.00224	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TRIB3—metabolic syndrome X	0.000408	0.00222	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000402	0.00219	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000385	0.00209	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.000369	0.00201	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—AGT—metabolic syndrome X	0.000368	0.002	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NAMPT—metabolic syndrome X	0.000366	0.00199	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000364	0.00198	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LIPC—metabolic syndrome X	0.000364	0.00198	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GCK—metabolic syndrome X	0.000364	0.00198	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOC3—metabolic syndrome X	0.000361	0.00196	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LEP—metabolic syndrome X	0.000361	0.00196	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AGT—metabolic syndrome X	0.000356	0.00193	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CETP—metabolic syndrome X	0.000351	0.00191	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000345	0.00188	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.000344	0.00187	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SCARB1—metabolic syndrome X	0.000336	0.00183	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000327	0.00178	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000327	0.00178	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SREBF1—metabolic syndrome X	0.000326	0.00177	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HMGCR—metabolic syndrome X	0.000317	0.00172	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GOT2—metabolic syndrome X	0.000317	0.00172	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000314	0.0017	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00031	0.00168	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—INS—metabolic syndrome X	0.000308	0.00168	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CCL2—metabolic syndrome X	0.000303	0.00165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	0.000298	0.00162	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF1—metabolic syndrome X	0.000298	0.00162	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GHRL—metabolic syndrome X	0.000297	0.00162	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL2—metabolic syndrome X	0.000293	0.00159	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000286	0.00155	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCA1—metabolic syndrome X	0.000283	0.00154	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC2A4—metabolic syndrome X	0.000283	0.00154	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CNR1—metabolic syndrome X	0.000281	0.00153	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GGT1—metabolic syndrome X	0.000274	0.00149	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GOT1—metabolic syndrome X	0.000274	0.00149	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HDAC3—metabolic syndrome X	0.000266	0.00145	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00024	0.00131	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000238	0.00129	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOB—metabolic syndrome X	0.000232	0.00126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TRIB3—metabolic syndrome X	0.000232	0.00126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RBP4—metabolic syndrome X	0.000232	0.00126	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLA2G4A—metabolic syndrome X	0.000226	0.00123	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LPL—metabolic syndrome X	0.000222	0.00121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL5—metabolic syndrome X	0.000218	0.00119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000217	0.00118	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CD36—metabolic syndrome X	0.000211	0.00115	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOC3—metabolic syndrome X	0.000205	0.00112	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGT—metabolic syndrome X	0.000201	0.00109	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARA—metabolic syndrome X	0.000196	0.00107	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AGT—metabolic syndrome X	0.00019	0.00103	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOE—metabolic syndrome X	0.000186	0.00101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR2C—metabolic syndrome X	0.000185	0.00101	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOA1—metabolic syndrome X	0.000184	0.000999	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGT—metabolic syndrome X	0.000183	0.000992	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CYBA—metabolic syndrome X	0.000179	0.000975	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GHRL—metabolic syndrome X	0.000176	0.000954	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CNR1—metabolic syndrome X	0.000166	0.000904	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARG—metabolic syndrome X	0.000162	0.00088	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—INS—metabolic syndrome X	0.000159	0.000863	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL2—metabolic syndrome X	0.00015	0.000817	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—metabolic syndrome X	0.000146	0.000792	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NOS3—metabolic syndrome X	0.000139	0.000757	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF2—metabolic syndrome X	0.000136	0.000739	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOB—metabolic syndrome X	0.000132	0.000717	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL5—metabolic syndrome X	0.000129	0.0007	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000128	0.000698	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—metabolic syndrome X	0.000127	0.000693	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LPL—metabolic syndrome X	0.000126	0.000685	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGT—metabolic syndrome X	0.000108	0.000586	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEP—metabolic syndrome X	0.000106	0.000574	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOE—metabolic syndrome X	0.000106	0.000574	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOA1—metabolic syndrome X	0.000104	0.000568	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	9.42e-05	0.000512	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—INS—metabolic syndrome X	9.02e-05	0.00049	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	8.88e-05	0.000483	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	8.73e-05	0.000474	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	8.29e-05	0.00045	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	7.91e-05	0.00043	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	6.78e-05	0.000369	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	6.68e-05	0.000363	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—metabolic syndrome X	6.4e-05	0.000348	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	6.16e-05	0.000335	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	5.23e-05	0.000284	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	3.94e-05	0.000214	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	3.64e-05	0.000198	CbGpPWpGaD
